Exchange: NASDAQ·Updated 07:41 PM EST

NAGE News

News
all
press releases
Niagen Bioscience (NAGE) Reports Q3 Loss, Lags Revenue Estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of 0.00% and -9.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Niagen Bioscience (NAGE) Reports Q3 Loss, Lags Revenue Estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of 0.00% and -9.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
Niagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced its operational updates and financial results for the third quarter of 2026. Third Quarter 2026 Financial and Business Highlights...
Business Wire
Will Coherus Oncology (CHRS) Report Negative Earnings Next Week? What You Should Know
Coherus Oncology (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to Decline
Niagen Bioscience (NAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Niagen Bioscience Launches Niagen Plus Liquid At-Home Injections to Support Telehealth Expansion
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of the clinician-directed, prescription-only pharmaceutical-grade Niagen At-Home Injection Kit, featuring the Companys...
Business Wire
Niagen Bioscience Makes Skincare a Permanent Tru Niagen Category, Launching Dermatologist-Tested Niagen NanoCloud as a Core Tru Niagen Product
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the debut of Tru Niagen Skincare, a permanent new category in the core Tru Niagen line, led by the Niagen Skincare Innovation Lab...
Business Wire
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Wednesday, November 4, 2026, at 4:30 p.m. ET to discuss its financial results for the third...
Business Wire
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that Radicle Science and Council for Responsible Nutrition (CRN) honored Andrew Shao, Ph.D., Senior Vice President of Global...
Business Wire
Niagen Bioscience to Present at LD Micro 20th Annual Main Event
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the 20th Annual LD Micro Main Event from Monday, October 19 to 21, 2026, in Los Angeles...
Business Wire
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better. a New Campaign for its Niagen Brand Featuring Legendary Surfer Kelly Slater
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Don't Get Old. Age Better., a new brand campaign for its Niagen (patented nicotinamide riboside, or NR) brand and...
Business Wire

Advertisement|Remove ads.